Published in Transl Neurodegener on September 13, 2014
First European consensus for diagnosis, management, and treatment of transthyretin familial amyloid polyneuropathy. Curr Opin Neurol (2016) 0.90
A Review of Tafamidis for the Treatment of Transthyretin-Related Amyloidosis. Neurol Ther (2015) 0.83
Neuroinflammation in the peripheral nerve: Cause, modulator, or bystander in peripheral neuropathies? Glia (2015) 0.80
Modulating inhibitors of transthyretin fibrillogenesis via sulfation: polychlorinated biphenyl sulfates as models. Chem Biol Interact (2015) 0.80
Recommendations for presymptomatic genetic testing and management of individuals at risk for hereditary transthyretin amyloidosis. Curr Opin Neurol (2016) 0.80
Green tea extract as a treatment for patients with wild-type transthyretin amyloidosis: an observational study. Drug Des Devel Ther (2015) 0.76
Novel conformation-specific monoclonal antibodies against amyloidogenic forms of transthyretin. Amyloid (2016) 0.76
Curcumin: A multi-target disease-modifying agent for late-stage transthyretin amyloidosis. Sci Rep (2016) 0.75
A New Folding Kinetic Mechanism for Human Transthyretin and the Influence of the Amyloidogenic V30M Mutation. Int J Mol Sci (2016) 0.75
Familial Amyloid Polyneuropathy Type IV (FINNISH) with Rapid Clinical Progression in an Iranian Woman: A Case Report. Iran J Med Sci (2016) 0.75
Genetic Prion Disease Caused by PRNP Q160X Mutation Presenting with an Orbitofrontal Syndrome, Cyclic Diarrhea, and Peripheral Neuropathy. J Alzheimers Dis (2016) 0.75
Gd-nanoparticles functionalization with specific peptides for ß-amyloid plaques targeting. J Nanobiotechnology (2016) 0.75
Novel Antibody for the Treatment of Transthyretin Amyloidosis. J Biol Chem (2016) 0.75
Genetic background modifies amyloidosis in a mouse model of ATTR neuropathy. Biochem Biophys Rep (2016) 0.75
Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature (1998) 72.56
Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature (2001) 57.23
Safety and efficacy of RNAi therapy for transthyretin amyloidosis. N Engl J Med (2013) 3.97
Cyclodextrin-based pharmaceutics: past, present and future. Nat Rev Drug Discov (2004) 3.68
Review: history of the amyloid fibril. J Struct Biol (2000) 3.49
Tafamidis for transthyretin familial amyloid polyneuropathy: a randomized, controlled trial. Neurology (2012) 3.48
The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid. Biochemistry (1996) 3.42
Cyclodextrin Drug Carrier Systems. Chem Rev (1998) 3.40
Classification of amyloidosis by laser microdissection and mass spectrometry-based proteomic analysis in clinical biopsy specimens. Blood (2009) 3.00
Fibril in senile systemic amyloidosis is derived from normal transthyretin. Proc Natl Acad Sci U S A (1990) 2.87
Diagnostic pitfalls in sporadic transthyretin familial amyloid polyneuropathy (TTR-FAP). Neurology (2007) 2.59
Protein aggregation kinetics, mechanism, and curve-fitting: a review of the literature. Biochim Biophys Acta (2008) 2.29
Tabulation of human transthyretin (TTR) variants, 2003. Amyloid (2003) 2.23
Amyloid fibril protein nomenclature: 2012 recommendations from the Nomenclature Committee of the International Society of Amyloidosis. Amyloid (2012) 2.21
Familial amyloid polyneuropathy. Lancet Neurol (2011) 2.15
Transthyretin aggregation under partially denaturing conditions is a downhill polymerization. Biochemistry (2004) 2.08
Cardiac amyloidosis: a treatable disease, often overlooked. Circulation (2011) 1.93
Transthyretin-related amyloidoses and the heart: a clinical overview. Nat Rev Cardiol (2010) 1.81
Natural history of transthyretin Val30Met familial amyloid polyneuropathy: analysis of late-onset cases from non-endemic areas. J Neurol Neurosurg Psychiatry (2012) 1.81
Antibodies to human serum amyloid P component eliminate visceral amyloid deposits. Nature (2010) 1.81
Transthyretin-related familial amyloidotic polyneuropathy. Arch Neurol (2005) 1.78
Biochemical subtyping of amyloid in formalin-fixed tissue samples confirms and supplements immunohistologic data. Am J Clin Pathol (2004) 1.77
Clinical indications for plasma protein assays: transthyretin (prealbumin) in inflammation and malnutrition. Clin Chem Lab Med (2007) 1.75
The systemic amyloidoses: clearer understanding of the molecular mechanisms offers hope for more effective therapies. J Intern Med (2004) 1.74
The transthyretin amyloidoses: from delineating the molecular mechanism of aggregation linked to pathology to a regulatory-agency-approved drug. J Mol Biol (2012) 1.70
Repurposing diflunisal for familial amyloid polyneuropathy: a randomized clinical trial. JAMA (2013) 1.69
Long-term effects of tafamidis for the treatment of transthyretin familial amyloid polyneuropathy. J Neurol (2013) 1.54
Transthyretin-derived amyloid deposition on the gastric mucosa in domino recipients of familial amyloid polyneuropathy liver. Liver Transpl (2007) 1.48
Primary localized amyloidosis of the urinary bladder: a case series of 31 patients. Mayo Clin Proc (2000) 1.47
The tetrameric protein transthyretin dissociates to a non-native monomer in solution. A novel model for amyloidogenesis. J Biol Chem (1999) 1.46
Changes in pathological and biochemical findings of systemic tissue sites in familial amyloid polyneuropathy more than 10 years after liver transplantation. J Neurol Neurosurg Psychiatry (2013) 1.46
Doxycycline modulates smooth muscle cell growth, migration, and matrix remodeling after arterial injury. Am J Pathol (2002) 1.41
Synthesis and evaluation of inhibitors of transthyretin amyloid formation based on the non-steroidal anti-inflammatory drug, flufenamic acid. Bioorg Med Chem (1999) 1.38
Polyneuritic amyloidosis in a Japanese family. Arch Neurol (1968) 1.34
Amyloid diseases of the heart: assessment, diagnosis, and referral. Heart (2011) 1.28
Amyloid deposits in transthyretin-derived amyloidosis: cleaved transthyretin is associated with distinct amyloid morphology. J Pathol (2005) 1.21
Chemical typing of amyloid protein contained in formalin-fixed paraffin-embedded biopsy specimens. Am J Clin Pathol (2001) 1.19
Type I (transthyretin Met30) familial amyloid polyneuropathy in Japan: early- vs late-onset form. Arch Neurol (2002) 1.19
Plasma retinol-binding protein: structure and interactions with retinol, retinoids, and transthyretin. Vitam Horm (2004) 1.17
Targeted suppression of an amyloidogenic transthyretin with antisense oligonucleotides. Muscle Nerve (2006) 1.17
Clinical development of an antisense therapy for the treatment of transthyretin-associated polyneuropathy. Amyloid (2012) 1.16
The course and prognostic factors of familial amyloid polyneuropathy after liver transplantation. Brain (2000) 1.13
The classification and typing of amyloid deposits. Am J Clin Pathol (2004) 1.12
Liver transplantation in transthyretin-related familial amyloid polyneuropathy. Curr Opin Neurol (2004) 1.11
Interaction of the anthracycline 4'-iodo-4'-deoxydoxorubicin with amyloid fibrils: inhibition of amyloidogenesis. Proc Natl Acad Sci U S A (1995) 1.08
Diagnosis of sporadic transthyretin Val30Met familial amyloid polyneuropathy: a practical analysis. Amyloid (2011) 1.07
Selective silencing of a mutant transthyretin allele by small interfering RNAs. Biochem Biophys Res Commun (2005) 1.06
Value of rectal biopsy in the diagnosis of primary systemic amyloidosis. Am J Med Sci (1966) 1.05
Amyloid in surgical pathology. Virchows Arch (2003) 1.05
Clinicopathological features of senile systemic amyloidosis: an ante- and post-mortem study. Mod Pathol (2011) 1.04
Progression of cardiac amyloid deposition in hereditary transthyretin amyloidosis patients after liver transplantation. Amyloid (2007) 1.03
Variation in amount of wild-type transthyretin in different fibril and tissue types in ATTR amyloidosis. J Mol Med (Berl) (2010) 1.03
Transmission of systemic transthyretin amyloidosis by means of domino liver transplantation. N Engl J Med (2005) 1.02
Long-term survival after liver transplantation in patients with familial amyloid polyneuropathy. Neurology (2012) 1.02
Mass spectrometric-based proteomic analysis of amyloid neuropathy type in nerve tissue. Arch Neurol (2010) 1.01
Liver transplantation for familial amyloidotic polyneuropathy (FAP): a single-center experience over 16 years. Am J Transplant (2007) 1.01
Transthyretin-derived senile systemic amyloidosis: clinicopathologic and structural considerations. Amyloid (2003) 1.00
Doxycycline disrupts transthyretin amyloid: evidence from studies in a FAP transgenic mice model. FASEB J (2006) 1.00
Classification of amyloidosis: misdiagnosing by way of incomplete immunohistochemistry and how to prevent it. Acta Histochem (2006) 0.97
4'-iodo-4'-deoxydoxorubicin and tetracyclines disrupt transthyretin amyloid fibrils in vitro producing noncytotoxic species: screening for TTR fibril disrupters. FASEB J (2003) 0.97
Mechanisms of transthyretin amyloidogenesis. Antigenic mapping of transthyretin purified from plasma and amyloid fibrils and within in situ tissue localizations. Am J Pathol (1994) 0.97
Liver transplantation and transthyretin amyloidosis. Muscle Nerve (2012) 0.96
Familial amyloid polyneuropathy: a clinico-pathologic study. J Neurol Sci (2009) 0.96
A different amyloid formation mechanism: de novo oculoleptomeningeal amyloid deposits after liver transplantation. Transplantation (2004) 0.94
Manifestations of transthyretin-related familial amyloidotic polyneuropathy: long-term follow-up of Japanese patients after liver transplantation. Surg Today (2011) 0.92
Anti-apoptotic treatment reduces transthyretin deposition in a transgenic mouse model of Familial Amyloidotic Polyneuropathy. Biochim Biophys Acta (2008) 0.92
Novel therapy for transthyretin-related ocular amyloidosis: a pilot study of retinal laser photocoagulation. Ophthalmology (2010) 0.92
Search for intermediate structures in transthyretin fibrillogenesis: soluble tetrameric Tyr78Phe TTR expresses a specific epitope present only in amyloid fibrils. J Mol Biol (2000) 0.92
High prevalence of wild-type transthyretin deposition in patients with idiopathic carpal tunnel syndrome: a common cause of carpal tunnel syndrome in the elderly. Hum Pathol (2011) 0.91
Amyloid fibril composition as a predictor of development of cardiomyopathy after liver transplantation for hereditary transthyretin amyloidosis. Transplantation (2012) 0.90
Gastric emptying before and after liver transplantation for familial amyloidotic polyneuropathy, Portuguese type (Val30Met). Amyloid (2003) 0.89
Transthyretin and amyloid in the islets of Langerhans in type-2 diabetes. Exp Diabetes Res (2008) 0.88
Targeted conversion of the transthyretin gene in vitro and in vivo. Gene Ther (2004) 0.87
High levels of messenger RNA for transthyretin (prealbumin) in human choroid plexus. Neurosci Lett (1986) 0.87
Early liver transplantation improves familial amyloidotic polyneuropathy patients' survival. Amyloid (2005) 0.87
Nodular senile pulmonary amyloidosis: a unique case confirmed by immunohistochemistry, mass spectrometry, and genetic study. Hum Pathol (2010) 0.86
Liver transplantation does not prevent the development of life-threatening arrhythmia in familial amyloidotic polyneuropathy, Portuguese-type (ATTR Val30Met) patients. Transplantation (2004) 0.85
Immunization in familial amyloidotic polyneuropathy: counteracting deposition by immunization with a Y78F TTR mutant. Lab Invest (2006) 0.85
Iatrogenic amyloid neuropathy in a Japanese patient after sequential liver transplantation. Am J Transplant (2006) 0.85
SELDI-TOF mass spectrometry evaluation of variant transthyretins for diagnosis and pathogenesis of familial amyloidotic polyneuropathy. Clin Chem (2009) 0.84
Synthesis and secretion of retinol-binding protein and transthyretin by cultured retinal pigment epithelium. Biochemistry (1994) 0.83
Regional differences and similarities of FAP in Sweden. Amyloid (2012) 0.83
The molecular interaction of 4'-iodo-4'-deoxydoxorubicin with Leu-55Pro transthyretin 'amyloid-like' oligomer leading to disaggregation. Biochem J (2000) 0.82
Wild-type transthyretin-derived amyloidosis in various ligaments and tendons. Hum Pathol (2011) 0.82
Micropurification techniques in the analysis of amyloid proteins. J Clin Pathol (2003) 0.81
Diagnosis and therapeutic approaches to transthyretin amyloidosis. Curr Med Chem (2012) 0.81
Suppression of choroid plexus transthyretin levels by antisense oligonucleotide treatment. Amyloid (2010) 0.81
The long-term impact of liver transplantation on kidney function in familial amyloidotic polyneuropathy patients. Transpl Int (2005) 0.80
Liver transplantation and new therapeutic approaches for familial amyloidotic polyneuropathy (FAP). Med Mol Morphol (2005) 0.80
Subcutaneous adipose tissue biopsy for amyloid protein studies. Methods Mol Biol (2012) 0.79
Spinal multifocal amyloidosis derived from wild-type transthyretin. Amyloid (2011) 0.79
A new diagnostic procedure to detect unknown transthyretin (TTR) mutations in familial amyloidotic polyneuropathy (FAP). J Neurol Sci (2000) 0.79
Long-term quantitative evaluation of liver transplantation in familial amyloid polyneuropathy (Portuguese V30M). Amyloid (2002) 0.79
Labial salivary gland biopsy for diagnosis of amyloid polyneuropathy. Muscle Nerve (1999) 0.79
Presence of variant transthyretin in aqueous humor of a patient with familial amyloidotic polyneuropathy after liver transplantation. Amyloid (2002) 0.78
A new simple and rapid screening method for variant transthyretin-related amyloidosis. Biochem Biophys Res Commun (1996) 0.78
Tongue necrosis and systemic vascular amyloidosis. Hum Pathol (2011) 0.76
Cyclodextrin, a novel therapeutic tool for suppressing amyloidogenic transthyretin misfolding in transthyretin-related amyloidosis. Biochem J (2011) 0.76
Liver transplantation for familial amyloid polyneuropathy. Hepatogastroenterology (1999) 0.75